GSK, Pfizer unveil HIV drug firm ViiV Healthcare
GlaxoSmithKline and Pfizer launched ViiV Healthcare, a specialty pharmaceutical company focused on HIV drugs. The firm has 17 products in its portfolio, including Pfizer's Selzentry and GSK's Kivexa, and intends to launch 10 treatments.
PharmaTimes (U.K.)
| 11/4
This story published in BIO SmartBrief on 11/05/2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|